Partnership & prescription workflow
What exactly is the partnership, from patient to delivery?
Pharmaneek coordinates patient acquisition, registration, payment, prescription routing, and non-clinical support. An independent licensed provider decides whether to prescribe. Your pharmacist independently reviews the prescription; the approved written workflow assigns medication sourcing, dispensing, labeling, verification, counseling, and shipping to named parties before activation. The patient receives delivery through that state-specific pathway.
Exactly what does the partner pharmacy do?
Your pharmacist independently reviews each prescription and accepts, clarifies, or rejects it. Dispensing, verification, counseling where required, and recordkeeping follow the state-specific written workflow. Nothing is automatically approved on your behalf.
Are we only reviewing prescriptions, or are we dispensing too?
This is not a review-only or license-rental arrangement. Your pharmacy’s actual dispensing, verification, counseling, and recordkeeping duties must be named in the approved state-specific workflow before you accept prescriptions.
How are prescriptions transferred to our pharmacy?
Pharmaneek routes them securely to the activated pharmacy. The transmission mechanism and your pharmacist’s receipt, clarification, and recordkeeping steps are agreed before activation.
Do prescriptions arrive through eScript or our pharmacy management system?
Pharmaneek routes prescriptions securely to an activated pharmacy licensed in the patient’s state. PioneerRx is streamlined; another pharmacy management system can follow an agreed workflow. Whether a particular prescription uses eScript or another transfer mechanism, and how your system receives it, must be confirmed in the written workflow before activation.
How does your system integrate with ours?
PioneerRx is streamlined; other systems require an agreed workflow. Ask the partner team to demonstrate the proposed handoff, exceptions, and record exchange for your specific pharmacy system before activation.
What happens after our pharmacist reviews a prescription?
The named parties complete sourcing, dispensing, labeling, verification, and delivery under the approved state-specific workflow. Eligible Completed Prescriptions are reconciled for the agreed dispensing fee.
Can we reject a prescription or pause routing?
Your pharmacist retains independent professional judgment and may refuse, delay, clarify, or reject a prescription when required by law or professional judgment. Your pharmacy sets daily capacity and may pause routing as the agreement provides; increases need written approval from both sides.
Is our pharmacy only lending its license?
No. The proposed arrangement is a bona fide dispensing-services relationship. Your pharmacy is not a nominal license holder and retains the professional authority, oversight, counseling, and recordkeeping duties required by law.
Is this exclusive, and can we terminate?
The proposed standard relationship is not exclusive unless an executed addendum says otherwise. Term, renewal, notice, transition of in-flight prescriptions, patient support, and records are controlled by the executed agreement.
Compounding & product sourcing
Who compounds and dispenses the medication?
When permitted by applicable law and the approved product pathway, medication may be sourced from an FDA-registered 503B outsourcing facility. That does not make the 503B the dispensing pharmacy for every order. The dispensing pharmacy, product source, preparation, verification, and release parties are identified in the approved state-specific workflow before activation. A retail pharmacy’s eligibility depends on that review; no pharmacy is asked to act as a nominal license holder.
Are these compounded GLP-1 medications?
A proposed product may be compounded when permitted for its state and product pathway. Request the current product schedule; do not assume that every product or prescription is compounded or follows the same sourcing arrangement.
Is semaglutide, tirzepatide, or both offered through this partnership?
Availability depends on the current product schedule, state, and approved workflow. Ask the partner team which products and formulations are eligible at your location; this page is not an inventory promise.
Does our pharmacy need to compound, and where is the supplying facility?
A pharmacy’s role is decided by the approved product and state-specific workflow; do not assume a retail pharmacy must compound or that every product follows a 503A or 503B pathway. Ask the partner team to identify the proposed source facility, its location, the applicable product pathway, and your pharmacy’s actual dispensing duties before agreeing to participate.
Can a regular retail pharmacy participate?
Potentially. Eligibility depends on its licenses, pharmacist responsibilities, the product pathway, and the approved state-specific workflow. Retail status alone is neither approval nor a requirement to compound.
Is Pharmaneek acting as a 503A pharmacy in this workflow?
Do not infer the participating facility’s role from a designation alone. Request the product schedule identifying each pharmacy or facility, its location and role, and the applicable state-specific legal review.
Is medication sourced from a 503B outsourcing facility?
It may be when permitted by applicable law and the approved product pathway. The particular source and its role must be identified in the product schedule; sourcing does not by itself determine which pharmacy dispenses.
Is Pharmaneek preparing the medication itself, or using another 503A or 503B facility?
That depends on the specific product and approved pathway. Pharmaneek’s own pharmacy, any separate source facility, and the dispensing pharmacy must be identified separately in the product schedule and state-specific workflow. Ask for the facility name, location, and role; a 503A or 503B designation alone does not establish who dispenses a particular prescription.
Where is the supplying or compounding facility located?
Ask for the name and location of the proposed source for your product and state. A location, including California, cannot be assumed from the partner pharmacy’s address.
Which GLP-1 products and formulations are included?
Product and state eligibility are reviewed before activation. Request the current product schedule to confirm whether semaglutide, tirzepatide, a particular strength, or a customized formulation is eligible for the proposed workflow. Compounded medications are not FDA-approved.
Who owns and pays for inventory?
Medication, ingredients, packaging, cold-chain materials, shipping, and inventory ownership are assigned in a written product and cost schedule before activation. The dispensing fee compensates dispensing-related services only.
Legal & regulatory requirements
What is the legal/regulatory structure of the partnership?
It depends on the state, product, and approved dispensing pathway. Before activation, the parties review applicable federal and state requirements, including post-shortage GLP-1 compounding rules, sourcing, pharmacist oversight, records, privacy, labeling, and delivery. Counsel determines whether a state-specific addendum or a particular central-fill, shared-services, or contract-dispensing structure is appropriate; this page is not a legal determination.
Are the compounded prescriptions patient-specific?
The answer depends on the product and approved sourcing pathway. The product schedule and legal review must establish whether patient-specific prescribing is required for the proposed workflow; do not infer it from a facility designation.
Are alternative strengths or customized formulations used?
Request the current product schedule for the exact strength and formulation. Each proposed product must be reviewed under current federal and state rules before activation; no particular formulation is promised here.
Is this model permitted under our state Board of Pharmacy rules?
That requires review for your state, product, licenses, and participating parties. Counsel and the pharmacy must approve a documented state-specific pathway before prescriptions route; this page cannot determine legality for a particular state.
Must the dispensing pharmacy be located or licensed in the patient’s state?
Applicable licensing and location requirements depend on the state and pathway. The parties verify the participating pharmacy’s permits and responsibilities for the patient’s state before routing any prescription.
How can one facility prepare medication when another pharmacy is named on the label?
Only under a reviewed, lawful product and dispensing pathway. The written workflow must identify the source, dispensing pharmacy, labeling and verification parties, and required records before activation.
How is patient information protected?
Each party must follow applicable privacy and security law. The parties execute a Business Associate Agreement when required and establish secure, minimum-necessary information exchange before activation.
Compensation & dispensing fees
How much does the pharmacy earn per prescription/fill?
The proposed dispensing fee is negotiated at $1.00–$2.50 for each eligible Completed Prescription, not automatically per patient or per month. Expected volume, complexity, workload, counseling, and fulfillment duties inform the rate. Eligible Completed Prescriptions are reconciled monthly; the executed agreement controls the final fee, eligible refills, payment timing, reporting, and any separately priced work.
Is $2.50 the maximum dispensing fee?
The public proposed base dispensing-fee range is $1.00–$2.50 per eligible Completed Prescription. The final base rate and any separately priced work are negotiated and recorded in the executed agreement; do not treat an illustrative example as a separate rate card.
Is payment per patient, prescription, fill, or month?
The proposed base fee is per eligible Completed Prescription, not per registered patient or automatically per month. Eligible prescriptions are reconciled monthly under the final agreement.
Do we get paid for refills, and is the dispensing fee our only compensation?
A refill earns a fee only when it qualifies as an eligible Completed Prescription under the executed agreement. The negotiated $1.00–$2.50 range applies to the base dispensing fee; additional work such as counseling encounters, complex prescriptions, or pharmacy-performed shipping may be priced separately in writing. Review the full fee and cost schedule before deciding whether the economics work for your pharmacy.
Who pays the pharmacy: Pharmaneek or the patient?
For applicable purchases through Pharmaneek-operated programs, Pharmaneek administers patient payment and the partner pharmacy’s eligible fee is reconciled separately under the agreement. The agreement specifies payment responsibilities, timing, and reporting; the pharmacy should not assume it collects patient payment.
Who collects patient payments, and is the program entirely cash-pay?
Pharmaneek is the merchant of record for applicable purchases made through Pharmaneek-operated programs and administers patient payment, receipts, refunds, and payment disputes, subject to the agreement. Unless separately agreed in writing, this is cash-pay, not a Medicare Part D, Medicaid, commercial insurance, or PBM network agreement; your pharmacy’s fee is reconciled separately.
Does our pharmacy collect a copay or bill insurance?
Not under the proposed cash-pay program unless the parties separately agree in writing. Pharmaneek administers applicable patient purchases through Pharmaneek-operated programs; the partner pharmacy’s compensation and any payment responsibilities are specified in the executed agreement.
How do we decide whether the fee makes economic sense?
Review the full written fee and cost schedule against your actual pilot workload, volume, counseling, shipping duties, and expenses. No earnings or patient count is guaranteed. Your pharmacy controls its capacity and must approve increases in writing.
What counts as a Completed Prescription?
An eligible prescription issued by an appropriately licensed prescriber, accepted and reviewed by your pharmacist, lawfully dispensed, released for shipment or delivery, and not voided, canceled, rejected, refunded before dispensing, or otherwise ineligible under the executed agreement.
Which transactions do not earn a fee?
Canceled or rejected prescriptions, duplicates, fraud, legally ineligible prescriptions, prescriptions never released for fulfillment, test transactions, administrative reversals, and other written exclusions do not earn a fee.
Who pays for extra services, shipping, and reships?
Medication, packaging, cold-chain materials, shipping, integration, and additional pharmacist labor are assigned in a written cost schedule. Manual clarifications, counseling encounters, replacement processing, complex prescriptions, after-hours service, required reporting, and pharmacy-performed shipping are priced separately when applicable. Refunds, chargebacks, and reships follow the executed agreement and written responsibility matrix.
Patient & prescription volume
What monthly prescription volume should the pharmacy realistically expect?
No monthly volume is guaranteed unless a separate written minimum-volume commitment is executed. The proposed pilot starts at 100–500 prescriptions over 30 days, agreed in writing; your pharmacy sets capacity and approves increases in writing. Ask the partner team for a current, clearly dated forecast for your state rather than relying on an illustrative stage or a quoted total patient count.
Does a quoted 20,000–30,000 patient figure mean monthly prescriptions, and how fast could volume grow?
Do not treat an unverified patient count as monthly prescription volume or a guarantee. Ask for a dated forecast that specifies whether a figure is monthly or cumulative, what counts as a patient versus a prescription, and the expected ramp for your state. Your pharmacy controls its daily capacity; increases require written approval.
How many patients will you actually send us?
No patient count is promised. Request a current, dated forecast for your state distinguishing patients from prescriptions and estimates from any written commitment.
Is a quoted patient figure monthly or total?
Never assume either. Ask for the forecast period, whether the number is cumulative or monthly, and whether it counts people, prescriptions, or fills.
Can our pharmacy choose how much volume to accept?
Yes, the proposed pilot and daily capacity are agreed in writing. Your pharmacy may pause routing as the agreement provides, and increases require written approval from both sides.
Is prescription volume guaranteed or estimated?
It is an estimate unless the parties execute a separate written minimum-volume commitment. Illustrative stages and patient figures are not guarantees.
Labeling & pharmacy identity
Whose name appears on the prescription and medication label?
The prescription and label must identify the legally appropriate dispensing pharmacy and pharmacist under the approved state-specific pathway. The written workflow names who generates and applies the label, how the label data moves between parties, and what each location verifies. We do not assume a supplier can use your pharmacy’s name without that review.
Do we provide our label template, including for multiple locations?
The approved workflow must specify how each participating location’s label data or template is supplied, who generates and applies the dispensing label, and who verifies it. A separate facility cannot simply place your name on a package without the applicable legal and operational review.
How does the supplying facility obtain our pharmacy’s label information?
The approved workflow specifies the secure exchange of each participating location’s label data or template, who may use it, and what your pharmacy verifies. No facility should use your name without the required legal and operational review.
Who generates and applies the dispensing label?
The named party must be identified in the state-specific written workflow. The workflow also documents pharmacist verification and how the legally appropriate dispensing pharmacy is identified.
Can another facility ship medication labeled with our pharmacy’s name?
Only if the proposed labeling, dispensing, and delivery arrangement is reviewed and permitted for the state and product. The workflow names every party and required verification step; your name cannot simply be added to another facility’s package.
What if we have several pharmacy locations?
Each participating location’s license, label data, dispensing responsibilities, and verification steps require separate review and identification in the written workflow. One label template does not authorize every location.
Shipping & logistics
Who ships the medication?
The shipping party is named in the approved state-specific workflow. Your pharmacy may propose its own shipping arrangement for review; do not assume either party ships every product.
What carrier, transit time, and shipping rate apply?
These depend on the product, location, and approved cold-chain workflow. Request the current written shipping and cost schedule for the proposed state and product; no universal overnight, two-day, or dollar rate is promised here.
What shipping service is currently used?
Ask for the current product- and state-specific shipping schedule. Carrier and service level are confirmed in the approved workflow, not promised universally on this page.
Is delivery overnight or two-day?
Transit time depends on the product, destination, and approved service level. Request the current written shipping schedule; neither overnight nor two-day delivery is promised for every order.
What does shipping cost, and who pays for it?
The written cost schedule assigns shipping, packaging, cold-chain materials, and any reships to named parties for the product and state. There is no universal shipping price on this page.
Are cold packs or other cold-chain materials used?
Packaging and temperature-control requirements depend on the medication and approved delivery pathway. The state- and product-specific workflow names the required materials, responsible party, and tracking steps.
Can our pharmacy ship the medication and quote its own cold-chain rate?
You may propose a shipping arrangement and rate for review. Whether your pharmacy ships, which cold-chain packaging or carrier is used, who pays, and how reships are handled must be approved and documented in the state-specific workflow and written cost schedule before activation.
Pharmacy workload & staffing
How much pharmacist/staff time does each prescription require?
There is no universal per-prescription time estimate. During the proposed pilot your pharmacy sets daily capacity; together we review actual review time, acceptance and clarification rates, and support load weekly. Integration steps and any additional labor are documented before scaling, which requires written approval.
How long does prescription review and approval take?
There is no verified standard time. The pilot measures actual review and clarification time in your pharmacy before either party approves a higher volume.
What does our pharmacist need to check?
Your pharmacist independently checks each prescription and performs the verification, counseling, and recordkeeping duties assigned by law and the approved workflow. The detailed checklist must be reviewed with your pharmacist before activation; there is no automatic approval.
What staffing workload would a much larger prescription volume create?
Do not size staffing from a quoted patient figure. Start with the agreed pilot, measure review time and exceptions, and have your pharmacy approve capacity increases in writing before scaling.
Will the portal reduce manual pharmacist work at high volume?
The pharmacy system and agreed workflow may reduce administrative handoffs, but no time savings or staffing level is guaranteed. Your pharmacist still independently checks each prescription and performs the duties assigned to your pharmacy. The pilot measures actual review and clarification time before either side approves scaling.
Patient support & liability
Who handles shipping, patient support, counseling and adverse-event calls?
Pharmaneek handles payment, routine non-clinical support, status updates, and refill outreach. The state-specific written workflow names the shipping party, carrier/service level, packaging, cold-chain requirements, costs, and delivery tracking; your pharmacy may propose its own shipping arrangement for review. Your pharmacy provides pharmacist counseling where required. Clinical complaints and adverse events follow a shared written escalation process; do not redirect an urgent clinical call without following that process.
Who contacts patients about their orders?
Pharmaneek handles routine non-clinical status updates and refill outreach. The approved workflow assigns pharmacist counseling and any clinical follow-up to qualified parties.
If our pharmacy’s name is on the label and a patient calls us, who helps them?
The workflow defines how your pharmacy handles its professional duties and routes routine non-clinical questions to Pharmaneek. Clinical concerns must follow the agreed escalation process, not be redirected blindly.
Who provides pharmacist counseling for medication questions?
Your pharmacy provides pharmacist counseling where required by law and the approved state-specific workflow. The written escalation plan identifies the appropriate contact for each clinical question.
Who handles adverse reactions or urgent clinical calls?
Follow the shared written clinical and adverse-event escalation process. Your pharmacy retains its professional duties; do not redirect an urgent clinical call to non-clinical customer service without following that process.
Can we redirect patient questions to Pharmaneek?
Routine non-clinical questions can follow the agreed support handoff. Medication counseling, adverse reactions, and other clinical concerns must follow the approved escalation process and applicable professional duties.
Who handles a medication-related complaint?
The clinical escalation and complaint process is documented before activation. Each party’s professional duties and liability allocation are governed by the applicable workflow and executed agreement, not by a blanket transfer of responsibility to customer service.
What liability does my pharmacy take on?
Each party is responsible for its own acts, omissions, and regulatory compliance. Allocation of liability, indemnities, and required insurance are set out in the executed agreement, which your counsel should review before signature.
What insurance coverage is required?
Each party maintains the coverage its agreement requires. Certificates are exchanged during credentialing; request ours before signing.
State licensing
Why does our state matter, and which states are open?
Prescriptions route only after the parties confirm the applicable licenses and state-specific workflow. We do not assume that one pharmacy’s license covers another location or state. Ask the partner team to confirm current state and product availability, including any California or Florida requirements, for your locations.
Which states is Pharmaneek currently licensed in?
Request current, verifiable license and permit information for the proposed product, pharmacy, and patient state. This page is not a current list of licensed states.
Is Pharmaneek licensed in Florida?
Ask the partner team for the current Florida license or permit details and the approved Florida-specific workflow, if one is proposed. No Florida license status is asserted here.
Can multiple licensed locations participate?
Potentially, subject to separate review of each location’s licenses, permits, responsibilities, records, and labeling. The participating locations and states must be named in the applicable written agreement or addendum before routing.
Can our licenses in multiple states be included in the agreement?
Potentially, but each participating pharmacy location and state requires its own license and product-pathway review. Eligible locations and states must be documented in the executed agreement or applicable addendum.
What happens if Pharmaneek later obtains its own license in our state?
A later license does not automatically change the partnership, routing, your pharmacy’s duties, or its compensation. Any proposed change must be reviewed for that state and documented under the executed agreement before the workflow changes.
Start date & onboarding
When would this start?
There is no fixed start date. Activation follows credentialing, legal and product review, the approved state-specific workflow, and executed agreements or addenda.
How quickly can we onboard?
Timing depends on credentialing, your locations and products, legal review, integration, and signed documents. Ask the partner team for a plan specific to your pharmacy; no universal turnaround is promised.
Which agreements must we sign before prescriptions start?
The final partner agreement, product and cost schedules, written state-specific workflow or addendum when required, and a Business Associate Agreement when required are reviewed before activation. Ask the partner team for the current document set; requesting the overview does not commit you to signing.
What documents are needed before activation?
Credentialing may request licenses, pharmacist-in-charge information, NPI, applicable DEA or NCPDP identifiers, state permits, insurance, ownership information, accreditation, and disciplinary-history disclosures. None is needed just to request program information.
Can our attorney review the agreement?
Yes. Your counsel may review the proposed terms and state-specific workflow before your pharmacy signs. The executed agreement, not this FAQ, controls the arrangement.
Can your attorney speak directly with our attorney?
Request a counsel-to-counsel discussion through the partner team. Scheduling and participation are arranged with the relevant parties; no consultation is guaranteed by this FAQ.